CFDE Data Portal | Search SLC25A5P5

	Label	Description
	SLC25A5P5 associations Collection (Entity type)	Associations for SLC25A5P5_associations
	SLC25A5P5 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SLC25A5P5 Gene (Entity type)	ENSG00000226421 - solute carrier family 25 member 5 pseudogene 5
	GSE173116 GSE173118 ML-7 8 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146612 amiodarone 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128730 neratinib OVCAR-8 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE130401 trametinib YAP 4 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193838 catechin 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193838 catechin 0 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS

SLC25A5P5 associations

Associations for SLC25A5P5_associations

SLC25A5P5 associations.tsv

A file from IDG as part of the Harmonizome project

SLC25A5P5

ENSG00000226421 - solute carrier family 25 member 5 pseudogene 5

GSE173116 GSE173118 ML-7 8 v 10 human dn

A Gene Set from LINCS

GSE146612 amiodarone 2 v 3 human up

A Gene Set from LINCS

GSE236502 paclitaxel 2 v 3 human up

A Gene Set from LINCS

GSE128730 neratinib OVCAR-8 4 v 2 human up

A Gene Set from LINCS

GSE130401 trametinib YAP 4 v 3 human dn

A Gene Set from LINCS

GSE193838 catechin 0 v 2 human dn

A Gene Set from LINCS

GSE193838 catechin 0 v 4 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.